NCT01538823已完成不适用
Urine Proteome of Surgical Patients and Healthy Volunteers.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 664
- 试验地点
- 1
- 主要终点
- evaluation of novel bio markers
研究概览
简要总结
The purpose of this study is to define early urinary biomarkers for diagnosis and prognosis of Renal Cell Carcinoma (RCC) with subsequent development of reliable, cost-effective, screening techniques.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •18 years and older
- •Planned procedure with presumptive diagnosis of RCC, bladder or prostate cancer OR control patient undergoing non-urological surgery OR normal healthy volunteer OR post surgical patient with a diagnosis of RCC and under surveillance for reoccurrence of RCC or treatment of metastatic RCC
- •Signed, informed consent
排除标准
- •Patients on dialysis
结局指标
主要结局
evaluation of novel bio markers
时间窗: 5 years
The overall objective of our study is to find and evaluate additional novel biomarkers, predictive of disease, that are present and measurable in whole urine of patients undergoing surgery for renal cancer.
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Urinary Biomarkers as Predictors on Renal Function in Congenital HydronephrosisUreteral ObstructionNCT00568724University of Aarhus45
已完成
不适用
Biomarker for Peritoneal Ultrafiltration FailureContinuous Ambulatory Peritoneal DialysisNCT00728806Sun Yat-sen University40
招募中
不适用
Urine Omics Predicting IO Therapy Responses in mUC PatientsMetastatic Urothelial CarcinomaNCT04641936National Taiwan University Hospital600
招募中
不适用
Urine Omics Predicting IO Therapy Responses in mRCC PatientsMetastatic Renal Cell CarcinomaNCT04712305National Taiwan University Hospital400
已完成
不适用
Urinary Biomarkers in the Detection of Urothelial Carcinoma of the BladderBladder Cancer, BiomarkersNCT02745301Vanderbilt University50